Synthes elects new Director to the Board
Solothurn/Switzerland, November 16, 2005At its last meeting the Board elected Jobst Wagner as a new Director. He will stand for re-election by the Shareholders on April 20, 2006.
Synthes’ Board of Directors consisted of eight directors. The maximum number of Directors to the Board has been increased by an extraordinary meeting of Shareholders in October 2003 to ten Directors. According to Delaware law and the Certificate of Incorporation of the Company the Board is entitled to elect directors until the next Annual Meeting of Shareholders.
Jobst Wagner is Swiss citizen and President of the Supervisory Board of the REHAU Group in Muri - Berne/Switzerland. Before assuming this position he held various functions within the REHAU organization, especially in purchasing and logistics. REHAU, a family owned company, is a leading polymer manufacturer and systems supplier in the construction, automotive and industry sectors with over 160 locations in 51 countries. Jobst Wagner is a Director of the Board of the Swiss private bank Von Graffenried AG. He graduated in law (lic.iur.) from the University of Berne.
Synthes: A leading medical device company
Synthes is a leading global medical device company. We develop, produce and market instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues.
For further information please contact
Peter Fehlmann, Investor Relations, Synthes, Inc.
Phone: +41 32 720 48 10 , Fax: +41 32 720 48 11
e-mail: ir.info@synthes.com